New York State Common Retirement Fund’s Agile Therapeutics AGRX Stock Holding History

New York State Common Retirement Fund’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Hold	0	–	-$1K	–	3586
2021 Q2	–	Sell	-22	Closed	-$72.5K	–	3513
2021 Q1	$92K	Sell	22 -9	-29%	-$48.6K	﹤0.01%	3096
2020 Q4	$179K	Hold	31	–	–	﹤0.01%	2795
2020 Q3	$189K	Hold	31	–	–	﹤0.01%	2677
2020 Q2	$173K	Buy	+31	New	+$161K	﹤0.01%	2707
2017 Q2	–	Sell	-5	Closed	-$30K	–	3260
2017 Q1	$30K	Hold	5	–	–	﹤0.01%	3098
2016 Q4	$54K	Hold	5	–	–	﹤0.01%	3059
2016 Q3	$66K	Hold	5	–	–	﹤0.01%	3056
2016 Q2	$72K	Hold	5	–	–	﹤0.01%	3049
2016 Q1	$58K	Hold	5	–	–	﹤0.01%	3030
2015 Q4	$92K	Hold	5	–	–	﹤0.01%	3028
2015 Q3	$63K	Buy	5 +2	+67%	+$35.5K	﹤0.01%	3090
2015 Q2	$43K	Buy	+3	New	+$64K	﹤0.01%	3223

Other funds holding AGRX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York State Common Retirement Fund's AGRX Position: Q3 2021 in Review

New York State Common Retirement Fund held its Agile Therapeutics (AGRX) position steady in Q3 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3586.

New York State Common Retirement Fund first reported a position in AGRX in Q2 2015 and has held it in 12 quarters since. The position peaked at $189K in Q3 2020. 49 funds tracked by Wall St. Rank hold AGRX as of Q3 2021.

New York State Common Retirement Fund held 0 shares of Agile Therapeutics worth $0 as of Q3 2021.
New York State Common Retirement Fund left its Agile Therapeutics share count unchanged in Q3 2021.
Agile Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q3 2021, its #3586 holding.
New York State Common Retirement Fund first reported a position in Agile Therapeutics in Q2 2015 and has held it in 12 quarters since.
New York State Common Retirement Fund's Agile Therapeutics position peaked at $189K in Q3 2020.
49 funds tracked by Wall St. Rank held Agile Therapeutics as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.